Increased adoption of clinical whole-genome sequencing is advancing diagnostics for rare diseases, which affect 15 million American children SAN DIEGO, Feb. 27, 2026 /PRNewswire/ -- Illumina, Inc.
Newborn babies admitted to the hospital's neonatal intensive care unit (NICU) rely on the quick decisions and rapid action of the medical team responsible for them. DNA testing is critical to ...
Earlier this year, PacBio announced a collaboration with global rare disease genomics program iHope (part of the Genetic ...
Next-generation DNA sequencing (NGS)—the same technology which is powering the development of tailor-made medicines, cancer diagnostics, infectious disease tracking, and gene research—could become a ...
Rare diseases, defined in the U.S. as conditions affecting fewer than 200,000 people, can take years, if not decades, to ...
Miami University’s Center for Bioinformatics and Functional Genomics (CBFG) has become one of the first institutions in the region to acquire the PacBio VEGA Benchtop System — a cutting-edge DNA ...
The genome is more than a linear code; it is a dynamic structure whose three-dimensional folding dictates how genes are regulated. Traditional sequencing technologies capture base-level variation but ...
Falls Church, Va.-based Inova has teamed up with Danvers, Mass.-based Veritas Genetics to provide genome sequencing and interpretation in MyMap. MyMap integrates Veritas’ genome sequencing technology, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results